HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Waldemar Vollmer Selected Research

Peptidoglycan (Murein)

1/2022Peptidoglycan biosynthesis is driven by lipid transfer along enzyme-substrate affinity gradients.
1/2021Staphylococcus aureus cell wall structure and dynamics during host-pathogen interaction.
1/2019Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.
11/2018Peptidoglycan editing by a specific LD-transpeptidase controls the muramidase-dependent secretion of typhoid toxin.
1/2018Peptidoglycan in obligate intracellular bacteria.
10/2016A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
1/2016Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells.
1/2015Discrete and overlapping functions of peptidoglycan synthases in growth, cell division and virulence of Listeria monocytogenes.
3/2008Bacterial peptidoglycan (murein) hydrolases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Waldemar Vollmer Research Topics

Disease

12Infections
01/2022 - 01/2012
2Lyme Disease (Disease, Lyme)
01/2019 - 01/2016
2Autolysis
01/2015 - 03/2008
1Bacterial Infections (Bacterial Infection)
01/2022
1Gram-Negative Bacterial Infections
01/2021
1Arthritis (Polyarthritis)
01/2019
1Synovitis
01/2019
1Typhoid Fever (Typhoid)
11/2018
1Acquired Immunodeficiency Syndrome (AIDS)
10/2016
1Relapsing Fever
01/2016
1Pneumonia (Pneumonitis)
10/2014
1Pneumococcal Infections
12/2013
1Inflammation (Inflammations)
08/2010
1Sepsis (Septicemia)
07/2009

Drug/Important Bio-Agent (IBA)

9Peptidoglycan (Murein)IBA
01/2022 - 03/2008
4Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2015
3EnzymesIBA
01/2022 - 03/2008
3Pharmaceutical PreparationsIBA
12/2019 - 12/2013
2LactamsIBA
03/2021 - 01/2015
2Interleukin-8 (Interleukin 8)IBA
03/2014 - 01/2012
1Carbapenems (Carbapenem Antibiotics)IBA
01/2022
1Amoxicillin (Wymox)FDA LinkGeneric
03/2021
1Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA
01/2021
1CytokinesIBA
01/2019
1AntigensIBA
01/2019
1Muramidase (Lysozyme)IBA
11/2018
1Peptidyl Transferases (Peptidyltransferase)IBA
11/2018
1Virulence Factors (Pathogenicity Factors)IBA
11/2018
1Biological ProductsIBA
01/2018
1Lipid AIBA
10/2016
1Colistin (Coly-Mycin)FDA Link
10/2016
1GlycosyltransferasesIBA
10/2016
1Lipoproteins (Lipoprotein)IBA
10/2014
1NucleotidesIBA
03/2014
1FosfomycinFDA Link
01/2013
1DNA (Deoxyribonucleic Acid)IBA
05/2012
1ChemokinesIBA
01/2012
1PolymersIBA
08/2010
1Choline (Choline Chloride)IBA
07/2009
1Polysaccharides (Glycans)IBA
07/2009